Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001193125-21-045260
Filing Date
2021-02-16
Accepted
2021-02-16 17:24:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B7 d64098d424b7.htm 424B7 283995
2 GRAPHIC g64098g11a65.jpg GRAPHIC 54195
  Complete submission text file 0001193125-21-045260.txt   359628
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-240147 | Film No.: 21641017
SIC: 2834 Pharmaceutical Preparations